Covered recipient · General Payments record
MELISSA KAYE KEMP
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,108.82
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $427.54 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $383.13 | 18 |
| Galderma Laboratories, L.P. | $44.41 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.86 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451234 | CMS |
| ABBVIE INC. | $3.99 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451236 | CMS |
| ABBVIE INC. | $9.68 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451238 | CMS |
| ABBVIE INC. | $2.77 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451240 | CMS |
| ABBVIE INC. | $5.92 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451242 | CMS |
| ABBVIE INC. | $14.19 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451244 | CMS |
| ABBVIE INC. | $12.45 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451246 | CMS |
| ABBVIE INC. | $5.24 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451248 | CMS |
| ABBVIE INC. | $6.85 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451250 | CMS |
| ABBVIE INC. | $6.44 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451252 | CMS |
| ABBVIE INC. | $4.82 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451254 | CMS |
| ABBVIE INC. | $135.30 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451256 | CMS |
| ABBVIE INC. | $40.18 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451258 | CMS |
| ABBVIE INC. | $64.28 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451260 | CMS |
| ABBVIE INC. | $17.86 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451262 | CMS |
| ABBVIE INC. | $18.84 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451264 | CMS |
| ABBVIE INC. | $21.74 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451266 | CMS |
| ABBVIE INC. | $4.72 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107451268 | CMS |
| Galderma Laboratories, L.P. | $20.06 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145368409 | CMS |
| Galderma Laboratories, L.P. | $24.35 | 12/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145368411 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.